QA: Akorn INC in us_pharma/2015

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000003116_2016_Akorn_INC.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0000003116, Akorn INC

  xvar xval
0 AssetsCurrent 751,156,000
1 IntangibleAssetsNetIncludingGoodwill 938,338,000
2 PropertyPlantAndEquipmentNet 179,614,000
3 remainder_Assets 243,602,000
4 LiabilitiesCurrent 231,512,000
5 LiabilitiesNoncurrent 1,259,633,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 663,535,078
8 SellingGeneralAndAdministrativeExpense 495,319,797
9 ResearchAndDevelopmentExpense 74,720,330
10 remainder_Expenses 320,132,909
11 remainder_Revenues 2,943,271,049
12 remainder_NetIncome -101,542,624
13 remainder_ComprehensiveNetIncome -1,857,303
  yvar yval
0 Assets 2,112,710,000
1 Liabilities 1,491,145,000
2 Expenses 1,553,708,114
3 Revenues 2,943,271,049
4 StockholdersEquity 621,565,000
5 NetIncome 1,288,020,311
6 ComprehensiveNetIncome 1,287,091,660
7 BaseVar 4,102,117,045
8 EconomicCapitalRatiobeforeLimitedLiability 1.47
9 EconomicCapitalRatio 2.65

Edgar->Model Mapping

Feature Distribution

Change over Time